You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KLRA Exercise Disclosure
Renaud Ronald C Jr · SEC Form 4 · Filed Jun 11, 2026
Exercise
Calculated transaction value
$0
Renaud Ronald C Jr CEO & President
KLRA
Transaction date
Jun 9, 2026
Public filing date
Jun 11, 2026
Filing lag
Filed 2 days later
KLRA daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 38,094 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-267493
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$199.99K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kailera Therapeutics, Inc. KLRA | Exercise | Jun 9, 2026 | $199.99K |
| Kailera Therapeutics, Inc. KLRA Current | Exercise | Jun 9, 2026 | $0 |